This one still concerns me.
There could be lots of possible explanations for it, but no one's providing them.
If you know what John Cunningham Virus does... then it would concern you too.
There could be lots of possible explanations for it, but no one's providing them.
If you know what John Cunningham Virus does... then it would concern you too.
It could be down to:
Increased testing and monitoring in at-risk groups.
Increased usage of MS drugs like natalizumab and ocrelizumab.
Increased testing and monitoring in at-risk groups.
Increased usage of MS drugs like natalizumab and ocrelizumab.
Increased immunosuppression from broader therapies (e.g., for transplants or autoimmune diseases).
Improved lab detection and reporting standards.
Improved lab detection and reporting standards.
Or there could be, you know, a biological cause.
Something like a virus that can damage your immune system and make you vulnerable to virus reactivation.
Something like a virus that can damage your immune system and make you vulnerable to virus reactivation.
Would be nice to know how many tests are being done, and under what circumstances, and whether the positive tests represent latent but unreactivated infections, or new ones, or reactivated ones.
I'm sure the UKHSA are all over it like slugs on dog poop.
The only good thing about the graph is that the numbers of positives are still small.
But you can see the trend, right?
But you can see the trend, right?
And the connections are documented.
pubmed.ncbi.nlm.nih.gov/37421487/
pubmed.ncbi.nlm.nih.gov/37421487/
• • •
Missing some Tweet in this thread? You can try to
force a refresh
